Justin C. Konje

ORCID: 0000-0001-9736-6938 · 13 papers in corpus
article 2024
·doi:10.1002/ijgo.15326

OBJECTIVES: This study aimed to determine the normal vasculature indices of the endometrium and to correlate them with those in various physiological states. METHODS: Women undergoing ultrasound at the Feto-Maternal Center, Qatar in 2020-20…

book-chapter 2017
·doi:10.1201/9781315385198-15
book-chapter 2017
·doi:10.1201/9781315385198-31
article 2011
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2011.02.013

ObjectivesThe levonorgestrel (LNG) intrauterine system (LNG-IUS) has been shown to improve symptoms in women with minimal to moderate endometriosis. The precise mechanism for this is unknown. We hypothesized that this involves alteration in…

article 2011
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2011.09.007

ObjectivesMirena® has been shown to improve symptoms in women with minimal to moderate endometriosis. The precise mechanisms for this have not been thoroughly investigated. We investigate here one possible mechanism-alteration in the number…

article 2011
·doi:10.1586/eog.11.32

Endometriosis is a complex and multifactoral disease with the evidence indicating that its pathophysiology is fractured and separated, often leading to it being referred to as the ‘disease of theories’. Here we present evidence on the invol…

article 2010
BMJ (Clinical research ed.) ·doi:10.1136/bmj.c2168

Background Intracranial fusiform aneurysms are less common than saccular aneurysms, but are associated with higher mortality and morbidity. We conducted this study to determine the safety and efficacy of the pipeline embolization device (PE…

article 2009
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2008.12.002

ObjectiveNot every patient with endometriosis responds to currently recommended conventional medical treatment regimens. The objective of this study was to determine the efficacy and side effects of aromatase inhibitors in the treatment of …

other 2005
Fertility and sterility ·doi:10.1016/j.fertnstert.2004.07.961

OBJECTIVE: To determine and compare levels of levonorgestrel (Lng) in serum and peritoneal fluid (PF) of patients on the Lng intrauterine system Mirena (Schering Health, Berlin, Germany) for endometriosis and to relate these to symptoms. D…

article 2005
·doi:10.1097/01.ogx.0000167406.63373.53

Most treatments used to date for endometriosis cause systemic side effects that not only may reduce compliance, but also preclude their long-term use. The levonorgestrel intrauterine system, which delivers the progestogen levonorgestrel dir…

article 2004
Human Reproduction ·doi:10.1093/humrep/deh650

BACKGROUND: Side-effects and choice of drugs influence compliance during treatment for endometriosis. Progestogen administered by a device with a 5-year lifespan, has been shown to be an effective medical alternative with several advantages…

article 2002
·doi:10.1016/s0015-0282(01)03086-2
book 1998

Contributors Preface Acknowledgements Introduction Part A: Gynaecology:Questions:Menstrual disorders Early pregnancy disorders Infertility and gynaecological endocrinology Endometriosis Pelvic inflammatory disease and genito-urinary medicin…